telmisartan has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiyo, T; Fujihara, S; Fujita, K; Iwama, H; Kobara, H; Kobayashi, N; Masaki, T; Matsui, T; Morishita, A; Nakahara, M; Namima, D; Nishiyama, N; Yachida, T | 1 |
| Damle, D; Patel, BM | 1 |
2 other study(ies) available for telmisartan and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclin A2; Cyclin-Dependent Kinase 2; Esophageal Neoplasms; Female; Humans; Mice; Mice, Inbred BALB C; Receptor, ErbB-3; S Phase; Telmisartan; Thrombospondin 1 | 2019 |
Combination of telmisartan with cisplatin controls oral cancer cachexia in rats.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Benzoates; Cachexia; Carcinoma, Squamous Cell; Cisplatin; Humans; Mouth Neoplasms; Rats; Telmisartan | 2013 |